Beyond The Printed Page

  1. Seattle Genetics Legacy Of Partnering

    The CEO of Seattle Genetics discusses the past, present, and future of some of his company’s partnerships.

  2. Clay Siegall Reveals What Surprised Him Most From Founding Seattle Genetics

    The CEO of Seattle Genetics reveals what surprised him about founding a biopharmaceutical company.

  3. Can Boston And San Francisco Remain The Center Of Biopharma’s Universe?

    Three top biopharmaceutical executives share their ideas on what bio clusters biopharmaceutical executives should be paying attention to for 2018. In addition, insights are provided on other future potential bio hot spots.

  4. Want To Know What 5 Biopharmaceutical CEOs Anticipate For 2018 & Beyond?

    Five top biopharmaceutical executives share their thoughts on Big Data, industry trends, personalized medicine, and more in preparing you for what to expect in 2018 – and beyond.

  5. Diverse Perspectives — Insights for 2018 From Biopharma’s Leading Women

    Five female biopharmaceutical industry CEOs share exclusive insights on what to expect for 2018 and beyond.

  6. Five Questions With Lilly’s Daniel Skovronsky, M.D., Ph.D.

    Daniel Skovronsky, M.D., Ph.D., former CEO of Avid Radiopharmaceuticals, sold his company to Eli Lilly and Company in 2010 for $300 million -- $850 million if you add in all the milestones achieved. This successful biopharmaceutical entrepreneur shares personal insights on the process of valuing his company prior to acquisition, his philosophy on optionality, and what if anything he’d do differently.

  7. A Woman Leader On The Subject Of Women As Leaders

    Can women leaders be responsible and liked – at the same time? Sophie Kornowski-Bonnet, head of Roche partnering, discusses her approach to overcoming adversity, leading to an interesting discussion on if there are differences beyond gender for male versus female executives.

  8. The Intriguing Career Path Of Roche’s Head Of Partnering

    What’s it take to get to the c-suite of a biopharmaceuticals company? For Sophie Kornowski-Bonnet, it was a willingness to step out of her comfort zone. The current head of Roche partnering and executive committee member, shares her intriguing career path, which began in Paris, France, back in 1986.

  9. Daniel Skovronsky – From Grad Student, To CEO, To Big Pharma

    Prior to joining Lilly as SVP of clinical and product development, Daniel Skovronsky, M.D., Ph.D. was CEO of Avid Radiopharmaceuticals — a company he founded while still a graduate student. This article is a prequel to the upcoming feature in our November issue that explores how he built a $300 million company.

  10. Does The Biopharmaceutical Industry Need To Broaden Its Horizons?

    When I interviewed Axovant Sciences CEO David Hung, one of the questions posed was sparked by our discussion of his experience at Pro-Duct Health and his invention of a microcatheter for early detection of ductal breast cancer in women. As he explained his medical device invention, Hung commented, “I don’t want to be just medicines, or just devices, or anything like that.”